1. Food and Drug Administration. Evaluation of Gastric pH Dependent Drug Interactions With Acid-Reducing Agents: Study Design, Data Analysis, and Clinical Implications: Guidance for Industry (Draft Guidance). Available at: https://www.fda.gov/media/144026/download. Accessed January 6, 2021.
2. Impact of acid-reducing agents on gastrointestinal physiology and design of biorelevant dissolution tests to reflect these changes;Segregur;J Pharm Sci,2019
3. Prediction of plasma profiles of a weakly basic drug after administration of omeprazole using PBPK modeling;Segregur;Eu J Pharm Sci,2020
4. Evaluating the impact of acid-reducing agents on drug absorption using biorelevant in vitro tools and PBPK modeling - case example dipyridamole;Segregur;Eu J Pharm Sci,2021
5. Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects;Iwamoto;Clin Pharmacol Ther,2008